Watson Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Quarter Ending Sep 09 (Prelim.) |
Quarter Ending Jun 09 |
Quarter Ending Jun 09 |
Quarter Ending Mar 09 |
Quarter Ending Mar 09 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash | 812.9 | 637.5 | 637.5 | 559.0 | 559.0 |
| Net Receivables | 377.1 | 356.6 | 356.6 | 353.6 | 353.6 |
| Inventories | 505.7 | 499.3 | 499.3 | 476.2 | 476.2 |
| Other Current Assets | 189.6 | 195.1 | 195.1 | 175.0 | 175.0 |
| Total Current Assets | 1,885.3 | 1,688.5 | 1,688.5 | 1,563.8 | 1,563.8 |
| Net Fixed Assets | 625.1 | 635.4 | 635.4 | 649.0 | 649.0 |
| Other Noncurrent Assets | 1,515.4 | 1,526.5 | 1,526.5 | 1,538.1 | 1,538.1 |
| Total Assets | 4,025.8 | 3,850.4 | 3,850.4 | 3,750.9 | 3,750.9 |
| Liabilities and Shareholder's Equity | Quarter Ending Sep 09 (Prelim.) |
Quarter Ending Jun 09 |
Quarter Ending Jun 09 |
Quarter Ending Mar 09 |
Quarter Ending Mar 09 |
| Current Liabilities | |||||
| Accounts Payable | -- | -- | -- | -- | -- |
| Short-Term Debt | 1.6 | 726.4 | 726.4 | 626.4 | 626.4 |
| Other Current Liabilities | 438.3 | 464.2 | 464.2 | 516.2 | 516.2 |
| Total Current Liabilities | 439.9 | 1,190.6 | 1,190.6 | 1,142.6 | 1,142.6 |
| Long-Term Debt | 997.4 | 150.0 | 150.0 | 250.0 | 250.0 |
| Other Noncurrent Liabilities | 277.9 | 277.7 | 277.7 | 194.7 | 194.7 |
| Total Liabilities | 1,715.2 | 1,618.3 | 1,618.3 | 1,587.3 | 1,587.3 |
|
Shareholder's Equity | |||||
| Preferred Stock Equity | -- | 0.0 | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 2,310.6 | 2,232.1 | 2,232.1 | 2,163.6 | 2,163.6 |
| Total Equity | 2,310.6 | 2,232.1 | 2,232.1 | 2,163.6 | 2,163.6 |
| Shares Outstanding (mil.) | 105.7 | 105.7 | 105.7 | 105.7 | 105.7 |
© 2009 Morningstar, Inc. Financial Data provided by
